3 Canadian LP's That Need To Be On Your Radar

The summer has been a rough time for Canadian cannabis stocks and Horizons Marijuana Life Sciences ETF (HMMJ.TO) (HMLSF) has fallen approx. 25% from its late June highs.

This weakness has taken place on light volume and we have been closely monitoring this trend. Although the decline has been painful, it does not come as a surprise. During the last three years, we have seen the cannabis sector pullback during the summer months and this year has been no different.

Canopy Growth to Acquire Hiku Brands to Strengthen Retail and Brand Portfolio

Canopy Growth Corporation ("Canopy Growth") (TSX:WEED) (NYSE:CGC) and Hiku Brands Company Ltd. ("Hiku") (CSE:HIKU) (together, the "Companies") are pleased to announce that they have entered into a definitive arrangement agreement (the "Agreement") pursuant to which Canopy Growth will acquire all of the issued and outstanding common shares of Hiku (the "Transaction").

MedReleaf and BioPharma Services Inc. announce Strategic Alliance

MedReleaf Corp. (TSX:LEAF) ("MedReleaf" or the "Company") and BioPharma Services Inc. (BioPharma) today announced they have entered into an exclusive agreement to conduct clinical research for cannabis and cannabis derived products. Under the agreement BioPharma will become an extension of MedReleaf's clinic development team.

Aurora Cannabis Signs Agreement with Heinrich Klenk GmbH & Co. KG

Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that the Company, through its wholly owned subsidiary Pedanios GmbH ("Pedanios"), has signed a collaboration agreement with Heinrich Klenk GmbH & Co. KG ("Klenk"), one of Europe's largest medicinal plant companies.

Organigram Announces First International Expansion Investment

Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQB: OGRMF) (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce it has entered a non-binding term sheet to acquire up to 25 per cent of alpha-cannabis Pharma GmbH ("Alpha-Cannabis Germany" or "ACG") located in Stadthagen, Germany.

Pages